ClinVar Miner

Submissions for variant NM_005982.4(SIX1):c.162G>A (p.Ala54=)

gnomAD frequency: 0.00031  dbSNP: rs150550985
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000221837 SCV000269827 benign not specified 2015-07-02 criteria provided, single submitter clinical testing p.Ala54Ala in exon 1 of SIX1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 0.1% (15/11556) of L atino chromosomes by the Exome Aggregation Consortium (http://exac.broadinstitut e.org; dbSNP rs150550985).
Illumina Laboratory Services, Illumina RCV000328781 SCV000387288 benign Branchiootic syndrome 3 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV000383302 SCV000387289 likely benign Autosomal dominant nonsyndromic hearing loss 23 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Invitae RCV000871377 SCV001013025 benign Branchiootic syndrome 3; Autosomal dominant nonsyndromic hearing loss 23 2024-01-19 criteria provided, single submitter clinical testing
GeneDx RCV001610531 SCV001833241 benign not provided 2018-09-10 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002500694 SCV002812393 likely benign Branchiootic syndrome 3; Autosomal dominant nonsyndromic hearing loss 23; Branchiootorenal syndrome 1 2021-09-28 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001610531 SCV004701255 likely benign not provided 2024-02-01 criteria provided, single submitter clinical testing SIX1: BP4, BP7

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.